Lung Neoplasms  >>  aldoxorubicin (INNO-206)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aldoxorubicin (INNO-206) / LadRx
NCT00472771: INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

Withdrawn
2
0
US
INNO-206
CytRx
Small Cell Lung Cancer
 
11/08

Download Options